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Abstract: The ability of an animal, normally dependent on aerobic respiration, to suspend breathing and enter an anoxic 
state for long term survival is clearly a fascinating feat, and has been the focus of numerous biochemical studies. When 
anoxia tolerant turtles are faced with periods of oxygen deprivation, numerous physiological and biochemical alterations 
take place in order to facilitate vital reductions in ATP consumption. Such strategies include reversible post-translational 
modifications as well as the implementation of translation and transcription controls facilitating metabolic depression. Al-
though it is clear that anoxic survival relies on the suppression of ATP consuming processes, the state of the cell cycle in 
anoxia tolerant vertebrates remain elusive. Several anoxia tolerant invertebrate and embryonic vertebrate models display 
cell cycle arrest when presented with anoxic stress. Despite this, the cell cycle has not yet been characterized for anoxia 
tolerant turtles. Understanding how vertebrates respond to anoxia can have important
 clinical implications. Uncontrollable 
cellular proliferation and hypoxic tumor progression are inescapably linked in vertebrate tissues. Consequentially, the mo-
lecular mechanisms controlling these processes have profound clinical consequences. This review article will discuss the 
theory of cell cycle arrest in anoxic vertebrates and more specifically, the control of the retinoblastoma pathway, the mo-
lecular markers of cell cycle arrest, the activation of checkpoint kinases, and the possibility of translational controls im-
plemented by microRNAs. 
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1. INTRODUCTION 
  Extreme hypoxia is central to a variety of diseases in-
cluding cardiac and pulmonary dysfunction as well as tumor 
progression [1]. Recent insights into the molecular mecha-
nisms of tumor growth have promised refined and effective 
cancer treatments. Although cancers are incredibly diverse, 
researchers have been searching for a small number of un-
derlying controls, whose unregulated activity is required for 
the development of all cancers [2]. Many studies examine 
cell cycle components as key players in the uncontrollable 
proliferation and the progression of tumor growth [2, 3]. Cell 
cycle regulation in hypoxic environments, similar to tumor 
cores, has shown great potential to expose the secrets of cell 
cycle arrest [2, 3]. In light of this, there has been an over-
whelming interest in the elucidation of the molecular mecha-
nisms regulating survival in various levels of oxygen depri-
vation [3]. Many of these studies focus on anoxia tolerant 
invertebrate models, embryonic vertebrates and cell lines, 
failing to address the complexity of developmentally mature 
vertebrate systems. Studies examining the anoxic cell cycle 
characteristics of brine shrimp (Artemia franciscana) em-
bryos, zebra fish (Danio rerio) embryos, nematodes 
(Caenorhabditis elegans) and fruit flies (Drosophila mela-
nogaster) have shown that there are specific stages where the  
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cell cycle can arrest during periods of anoxia; however, the 
exact mechanism of this arrest has not been proposed but 
may be dependant on developmental stage and/or species [3-
7]. Although arrest pathways appear to be highly conserved 
throughout evolution, examination of a higher vertebrate 
animal model may prove to be useful in elucidating general 
mechanisms of vertebrate cell cycle arrest in response to 
hypoxia. Studies of this nature will prove useful for deter-
mining commonalities of cycle arrest utilizing wide com-
parative data between biologically diverse organisms.  
  In this review, we first attempt to summarize the most 
relevant biochemical information for cell cycle progression 
with particular emphasis on the molecular pathways of cell 
cycle regulation. We then discuss this information in the 
context of recent studies of anoxia tolerant invertebrates and 
embryonic vertebrate model systems as well as the proposed 
mechanisms of hypoxia induced cell cycle arrest. Finally, we 
consider the implications of these findings in regards to fu-
ture studies in the red-eared slider (Trachemys scripta ele-
gans); a vertebrate organism known to facilitate metabolic 
rate depression in response to severe anoxia.  
2. THE CELL CYCLE 
  The cell cycle consists of a series of events up to and 
including cellular division. The typical eukaryotic cell cycle 
consists of four distinct phases: G1 phase, S phase, G2 phase, 
and M phase. Cells that have reversibly exited the cell cycle 
are stated to have entered a quiescence state, G0. The first 
Gap phase (G1) functions to ensure that mechanisms are in 574    Current Genomics, 2009, Vol. 10, No. 8  Biggar and Storey 
place to control proper DNA synthesis. In some instances, 
this phase can be delayed to ensure proper DNA replication 
via the G1 checkpoint [8]. This phase is then followed by a 
synthesis phase (S) facilitating the complete replication of 
DNA. After successful DNA replication, a subsequent gap 
phases (G2) ensures that DNA replication has properly oc-
curred. If inappropriate DNA replication has occurred, the 
cell arrests via the G2 DNA-damage checkpoint before enter-
ing mitosis (M phase). After M-phase and successful com-
pletion of cell division, each daughter cell begins the G1 
phase of a new cycle. Each interphase (G1, S and G2 phases) 
of the cell cycle has a distinct set of specialized biochemical 
processes that ultimately prepare the cell for the initiation of 
mitosis [8, 9]. 
  Cell cycle control is implemented through a series of 
checkpoints that monitor and regulate the progress of the 
cycle. Proliferating cells cannot proceed through the cell 
cycle until individual checkpoint requirements have been 
met. Two main checkpoints exist capable of reversible arrest; 
these include the G1 checkpoint and the G2 checkpoint. The 
G1/S transition is a rate-limiting step known as the restriction 
point (R-point) characterized by Rb hyperphosphorylation 
and controlled through a delicate balance of mitotic and anti-
mitotic extracellular signals [9, 10]. Inactivation of this Rb-
E2F pathway characterizes the typical G1 checkpoint. An-
other important player in triggering the control mechanisms 
of both G1 and G2 checkpoints are the ATM/ATR checkpoint 
kinases [reviewed below]. 
Retinoblastoma and the Cell Cycle 
  The retinoblastoma (Rb) gene was the first tumor sup-
pressor to be discovered and as a result, has become a well-
established member of cell cycle control [11, 12] First identi-
fied in its mutant form in the rare eye tumor, retinoblastoma, 
the Rb gene is known to be inactivated in nearly all human 
cancers, signifying its importance in the cell cycle regulation 
and the maintenance of proliferation [11-13]. The Rb family 
(pRb/p105, pRb2/p130 and p107) was initially envisioned as 
simple “on-off” switches regulating the progression of the 
cell cycle. However, recent studies have revealed a complex 
set of Rb:protein interactions and binding properties, adding 
to the importance of Rb in cell cycle regulation [11]. As a 
result, Rb has been shown to have a specialized role in cell 
cycle exit leading to senescence and quiescence as well as 
the ability to pause the cell cycle and block apoptosis [11-
13]. These characteristics make Rb protein an intriguing tar-
get for analysis in the cell cycle systems of facultative an-
aerobiosis in which cells must temporarily inhibit mitosis to 
conserve energy stores.  
  Cellular proliferation involves the inactivation of at least 
one member of the retinoblastoma family thereby leading to 
differential binding properties and phosphorylation specific 
Rb markers characterizing the G1/S transition [14]. The gen-
eral mechanism by which the Rb family exerts its effects is 
through regulatory binding of the E2F family, inhibiting 
E2F-mediated transcription of cell cycle-dependent genes 
such as A and E type Cyclins [15, 16]. Phosphorylated 
pRb/p105 is present at relatively constant levels throughout 
the cell cycle; however, at the G1/S transition point it is se-
quentially phosphorylated by Cyclin D:Cycle dependant 
kinase (Cdk) 4/6 and Cyclin E:Cdk 2 complexes, respec-
tively, leading to a release of E2F and allowing cell cycle 
progression ([11, 17, 18]; Fig. (1)).  
  Unlike pRb/p105, which remains at relatively constant 
protein levels, p107 and pRb2/p130 are both dynamically 
regulated at the protein and post-translational level [19, 14]. 
Protein levels of p107 are maintained low during quiescence 
and are expressed at higher levels during G1 phase, parallel 
to that of pRb/p105 [16, 19]. In an expression pattern oppos-
ing p107, pRb2/p130 is maintained at lower levels in cycling 
cells and increases dramatically during quiescence [16, 19]. 
The rise in pRb2/p130 protein and mRNA levels at the qui-
escence stage is accompanied by a hypophosphorylated state, 















Fig. (1). The Rb:E2F pathway. Sequential phosphorylation by kinase complexes Cyclin D:Cdk 4/6 and Cyclin E:Cdk 2, respectively, causes 
conformational changes to the Rb structure and release of E2F. The release of E2F is necessary for the expression of S-phases genes. Perspectives in Cell Cycle Regulation  Current Genomics, 2009, Vol. 10, No. 8    575 
ing in the repression of genes required for re-entry into the 
early G1 phase.  
  As previously mentioned, phosphorylation of Rb in the 
late G1 phase regulates passage through the R-point transi-
tion, committing cells to mitosis. By contrast, hypophos-
phorylated Rb represses E2F through two main mechanisms 
1) by binding the E2F transactivation domain and 2) the re-
cruitment of chromatin remodeling complexes [17]. The 
multiple protein interactions of pRb/p105, pRb2/p130 and 
p107 are largely controlled by the serine and threonine phos-
phorylation [20, 21]. Cycles of phosphorylation and dephos-
phorylation of pRb/p105 and p107 dominate within cycling 
cells and in contrast, cells undergoing quiescence harbor 
pRb2/p130:E2F-4 as the main pocket protein complex [13, 
21]. The pRb2/p130:E2F-4 complex mediates the repression 
of cell cycle regulators including E2F members 1 through 3, 
Cdk 1 as well as Cyclins A and E [21]. When external mito-
gens signal cells re-enter the cell cycle, pRb2/p130 becomes 
hyperphosphorylated and, like pRb/p105 and p107, under-
goes conformational changes, losing its repressive abilities 
[22]. Three amino acid residues located within pRb2/p130 
(Serines 672, 952 and Tyrosine 401) are necessary for the 
disruption of E2F-4 repression [22]. In addition to phospho-
regulation of the Rb family, pRb/p105 control through p300-
dependant acetylation has been reported and is thought to 
regulate the G1/S transition by inhibiting kinase binding and 
Rb phosphorylation [23]. Thus, pRb/p105 acetylation (Lys 
382) may act as an important regulatory control.  
  Interest in the E2F family of transcription factors in-
creased dramatically when it was discovered that E2F, mem-
bers -1 through -5, complexed with Rb [24]. Knowledge that 
E2F regulated the cell cycle provided a mechanism by which 
Rb could repress cellular proliferation [25]. The E2F family 
is comprised primarily of five members, E2F-1, -2 and -3 
that interact exclusively with pRb/p105 and p107, as well as 
E2F-4 and -5 which interact with pRb2/p130 and to a lesser 
degree p107 [25]. On the basis of sequence homology and 
functional properties, E2F-1 through -3 are potent transcrip-
tional activators and will be referred to as ‘activating’ E2Fs. 
In contrast, E2F-4 and -5 are primarily involved in active 
repression of E2F targeted genes by recruiting pRb2/p130 
and associated chromatin remodeling complexes; these E2Fs 
will appropriately be referred to as ‘repressive’ E2Fs 
throughout the remainder of this review [24].  
Cyclins, Cdks and Cdk Inhibitors 
  Cellular proliferation is initially driven from the presence 
of extrinsic mitogens [26]. The presence of growth factors 
triggers signal cascades which, exert regulatory effects 
within the cytoplasm. These growth factors lead to sequen-
tial activation of Cdks, the central driving force of the cell 
cycle [19, 26, 27]. Initial activation of Cdk 4 and 6 leads to 
sequential phase-specific Cdk activation, creating a hierar-
chal system ensuring that one phase of the cell cycle is com-
pleted before the initiation of the next ([26]; Fig. (2)). The 
ordered progression through cell-cycle phases is controlled 
by the sequential phosphorylation and activation of Cdks 
4/6, Cdk 2, and Cdk 1 [19]. Cdk activity is regulated by sev-
eral mechanisms including binding of a Cyclin regulatory 
subunit, post-translational modifications and the associa-
tion/disassociation with Cdk inhibitors (CKIs).  
  Mitogenic growth factors begin the cycle through the 
Ras/Raf/ERK pathway, activating transcription factors re-
sponsible for Cyclin D expression [27]. Cyclin D then as-
sembles with Cdk 4/6 to form Cyclin D:Cdk 4/6 kinase com-
plexes, carrying out the initial phosphorylation of pRb/p105 
(residues Ser 780, Ser 795, Thr 807/11 and Thr 821) and 
marking the mid G1 phase [27, 28]. Following Cyclin D:Cdk 
4/6 activation and the initial phosphorylation of Rb, Cyclin E 
(E1 and E2) is expressed by internal E2F signaling path-
ways, marks the entry into late G1 phase and the R-point 
transition [12]. Cyclin E forms an active kinase complex 
with Cdk 2, leading to final phosphorylation and complete 
inactivation of pRb/p105 (residues Ser 608, Ser 612 and Ser 
567), dissociating the Rb-E2F complex and allowing the 
expression of genes required for S-phase entry and DNA 
replication [22, 29]. Soon after Cyclin E is expressed at the 
G1/S boundary, cells commit to mitosis and begin to express 
Cyclin A (A1 and A2). The increase of Cyclin A/Cdk 2 













Fig. (2). Expression profiles of Cyclin:Cdk complexes throughout the cell cycle. Cyclic expression of these complexes allow for the comple-
tion of one phase before the initiation of the subsequent phase [107]. 576    Current Genomics, 2009, Vol. 10, No. 8  Biggar and Storey 
chinery and is characteristic of the S-phase [30]. After com-
pletion of the S-phase and DNA replication, entry into G2 is 
marked by the expression of Cyclin B (B1, B2 and B3) and 
inactive Cyclin B:Cdk 1 complexes, in addition to the switch 
from Cyclin A:Cdk 2 complexes to the expression of active 
Cyclin A:Cdk 1. Cyclin B:Cdk 1 remains inactivate late into 
the G2 phase pending Cyclin B localization to the nucleus 
and Cdk 1 activation [30-32]. Targets of the Cyclin B:Cdk 1 
complex include structural proteins involved in the execution 
and timing of mitotic events [reviewed in 26, 33, 34]. Simi-
lar to Cdk activation, Cyclin:Cdk complexes trigger the acti-
vation of the subsequent and as a result appears to be self-
regulating, driving the cell cycle further through progression. 
During periods of cellular stress, the inhibition of Cy-
clin:Cdk complexes at the G1 checkpoint ultimately lead to 
the disruption of the cycle and inhibits the downstream acti-
vation of Cyclin:Cdk complexes. The cyclic expression of 
Cdks and Cyclins driving specific phases of the cell cycle 
allows for the use of cell cycle markers that when compared, 
can yield the cell cycle phase of synchronized cells ([19]; 
Fig. (2)).  
  The basic framework of the cell cycle consists of Cy-
clin:Cdk complex formation, initiating the pre-activation of 
Cdks. The dependence of Cdk activity on Cyclin binding 
represents the primary mechanism whereby Cyclins mediate 
the reconfiguration of residues involved in ATP binding and 
the repositioning of the T-loop [10]. Beginning from quies-
cence, the introduction of growth factors allow for a depres-
sion of Cdk inhibitors and an increased expression of the 
first Cyclin present in the cell cycle, Cyclin D (D1, D2, and 
D3) [26]. Since Cdk 4/6 proteins are expressed at relatively 
constant levels throughout the cell cycle, the expression of 
Cyclin D is the rate-limiting step in Rb phosphorylation, 
even during early G1 when Cdk 4/6 expression is highest 
[35]. In addition, Cyclins play an additional regulatory role 
through nuclear and cytoplasmic shuttling of Cdks thereby 
suggesting a role where Cyclins act to regulate the cell cycle 
in a manner discrete from just-in-time expression ([10]; Fig. 
(2)).  
  A recent study has shown that Cyclin D is upregulated in 
response to growth factors acting through the 
PI3K/AKT/mTOR pathway. As a response to the effect of 
mTOR on translational machinery, this study concluded that 
PI3K was absolutely necessary for induction of Cyclin D 
translation [36]. It has also been established in the literature 
that in response to environmental stresses, such as hypoxia, 
C.elegans enters a quiescent dauer stage effectively shutting 
down the PI3K/AKT/mTOR pathway and reducing transla-
tional activity [37]. Hence, the severe environmental stress 
response pathway seen in C.elegans may be mirrored in 
other stress tolerant organisms leading to reductions in Cy-
clin D expression and most likely playing a role in cell cycle 
arrest.  
3. CELL CYCLE REGULATION 
Stress Activated Checkpoint Pathways 
  Checkpoint pathways ensure error-free DNA replication 
and chromosome segregation, thereby tightly regulating cell 
cycle transitions and ensuring the maintenance of genomic 
integrity. Such checkpoints are comprised of apical signal 
transducing kinases such as phosphatidylinositol 3-kinase 
(PI3K)-like family members ATR and ATM kinases [38, 
39]. These kinases regulate the distal serine/threonine signal 
transducing kinases, Checkpoints 1 and 2 (Chk1 and Chk2). 
These distal kinases regulate a diverse group of effector pro-
teins encompassing cell cycle regulators such as cdc25 phos-
phatase, p53, E2F-1, Cyclin:Cdk complexes, and chromatin 





















Fig. (3). The ATM/ATR DNA damage response pathway and its 
downstream effectors leading to either G1/S or G2/M phase arrest. 
  To prevent inappropriate entry into both S and M phases, 
cells progressing though the G1 and G2 phases, respectively, 
activate the checkpoint transducing kinases ATR/ATM and 
Chk1/2. ATM-activated Chk2 primarily targets two critical 
effectors mediating the G1 checkpoint, cdc25a and p53 [38]. 
Phosphorylation of cdc25a, the primary phosphatase respon-
sible for Cdk 2 activation, by Chk2 at residue Ser 123 leads 
to enhanced ubiquitination and proteasome-mediated degra-
dation [39]. In contrast to cdc25a, p53 is phosphorylated by 
Chk2 at sites Ser 15 and 20, stabilizing p53 expression and 
leading to enhanced transcriptional activity [38]. One key 
gene upregulated by p53-mediated transcription is the Cdk 2 
inhibitor, p21 [reviewed below]. Accumulation of p21 is 
capable of inducing G1 arrest by blocking Cyclin E:Cdk 2 
activity, thereby maintaining pRb/p105 in a hypophosphory-
lated state and E2F repression. ATR/Chk1 activation of the 
G2 checkpoint prevents cells from entering mitosis when 
subject to DNA damage [40]. The key downstream target of 
the G2 checkpoint is the Cyclin B:Cdk 1 kinase complex. 
Activation of Cyclin B:Cdk 1 is prevented primarily through 
Chk1-mediated phosphorylation (Ser 216) and inhibition of Perspectives in Cell Cycle Regulation  Current Genomics, 2009, Vol. 10, No. 8    577 
cdc25c phosphatase, the activating phosphatase responsible 
for Cdk1 activation at the G2/M boundary [40]. Ultimately, 
the ATM/ATR checkpoint pathway mediates its effects by 
inhibiting Cdks, the primary motors of the cell cycle.  
  Although hypoxia does not itself induce DNA damage or 
a typical DNA damage response, several studies have indi-
cated the hypoxia-induced phosphorylation and activation of 
Chk2 in an ATM-dependant manner [41, 42]. Although the 
mechanisms for this arrest have not been clearly defined, 
hypoxia induced a rapid G1 arrest similar to that induced 
through DNA damage [41]. In addition, hypoxia activated 
Chk2 induces cell cycle arrest through similar mechanisms 
as DNA damage; this includes the activation and stabiliza-
tion of p53 and targeting cdc25a for degradation. Activation 
of Chk2 may prove to be a crucial mechanism initiating hy-
poxic cell cycle arrest.  
Regulation of cdk Complexes 
  Similar to the Rb family of pocket proteins, Cdks are 
subject to cycles of regulation via reversible phosphoryla-
tion. As previously mentioned, the binding of Cyclins to 
Cdks yield partial activation, however, complete activation 
requires neighboring phosphorylation of the Cdk ATP bind-
ing cleft. Activating phosphorylation of Cdks occurs on a 
conserved T-loop threonine residue (Thr 160 in Cdk 2, Thr 
161 in Cdk 1 and Thr 172 in Cdk 4/6) mediated by the 
threonine kinase, Cdk-activating kinase (CAK). The phos-
phorylation of Cdks by CAK is antagonized by the specific 
phosphatase activities of KAP, which acts on monomeric 
Cdks after Cyclin degradation ([43]; Fig. (4)). 
  In addition to cyclin-dependent regulation of Cdk activ-
ity, other important mechanisms of regulation of Cyclin:Cdk 
complexes are mediated through inhibitory proteins, CKIs. 
These inhibitors have been classified into two families, 
INK4 and Cip/Kip, based on their mechanisms of inhibition 
[44, 45]. The INK4 family of Cdk inhibitors (p16INK4a, 
p15INK4b, p18INK4c and p19INK4d) has been found to 
regulate monomeric Cdks 4 and 6. INK4:Cdk binding over-
laps the Cdk region responsible for Cyclin binding, thus 
blocking the formation of the Cyclin:Cdk complex and in-
hibiting Cdk function [26, 46]. The Cip/Kip family of inhibi-
tors (p21, p27 and p57) inhibits both monomeric Cdks and 
Cyclin:Cdk complexes [47, 48]. Binding of the Cip/Kip fam-
ily to Cdks can completely shut down the active Cyclin:Cdk 
complex through the insertion of a small 3
10-helix into the 
Cdk catalytic cleft, antagonizing the interactions of ATP 
substrate [49].  
  The Cip/Kip inhibitors, p21 and p27, are both expressed 
during quiescence and are thought to be responsible for the 
characteristically low levels of Cyclin:Cdk complexes [19]. 
A decrease in p27 and p21 allows for increased formation of 
active Cyclin:Cdk complexes leading to phosphorylation of 
Rb and re-entry into the cell cycle. The maintenance of qui-
escence is self-sustaining, through the combinatory effects of 
CKIs, in the absence of mitogenic stimuli. These stimuli 
eventually lead to the active phosphorylation of Cdks and the 
decrease of CKIs [19, 50].  
  Several studies have indicated that hypoxia-inducible 
factor 1 (HIF-1) plays an essential role in the adaptive 
response of cells to hypoxia [51]. In hypoxic environments, 
HIF-1 has a recognized role in the reorganization of glyco-
lysis and has recently been indicated in the cessation of cel-
lular proliferation through the induction of CKIs. A recent 
study by Horree has suggested that an increase in HIF-1 
transactivation activity increases the expression of p27 [52]. 
Complimentary studies using HIF-1 null murine embryonic 
fibroblasts identified p27 as having a role hypoxia-induced 
cell-cycle arrest and that this expression is indeed HIF-1 
dependant [53]. The HIF pathway may play an important 
role in connecting typical hypoxia response to the induction 
of cell cycle arrest. 
Retinoblastoma and Cell Cycle Arrest 
  Cells rely on several main pathways to regulate and 
maintain a quiescent state. These pathways converge on the 
necessity of pRb2/p130 and CKIs [47, 48, 53, 54, 55]. The 
Rb family member pRb2/p130, recruits the repressive E2F-4 
to E2F target promoters and facilitates binding to chromatin-
remodeling complexes [54]. This chromatin remodeling 
blocks the transcription of many positive regulators of the 
cell cycle. In addition, quiescence may be marked through 
site specific phosphorylation of pRb2/p130. Several studies 
have demonstration that the Loop region in the B pocket of 












Fig. (4). Mechanism of Cdk activation involving regulatory phosphorylation and Cyclin binding. 578    Current Genomics, 2009, Vol. 10, No. 8  Biggar and Storey 
phosphorylation of pRb2/p130 at sites Ser 948, Ser 966, Ser 
962, and Ser 982 in a GSK3 dependant manner [55]. This 
region, however, is not essential for those functions of 
pRb2/p130 associated with the ability to block the cell cycle 
progression and include the interactions with E2F-4, Cyclins 
A and E, and the LXCXE-containing proteins; nevertheless 
this phosphorylation pattern does provide a novel indicator 
of cellular quiescence [55].  
  Heterochromatin is composed of genomic DNA tightly 
packed by histones and non-histone proteins [56, 57]. Dy-
namic changes to chromatin structure prevent the access of 
transcription factors, such as E2F, to nucleosomal DNA. At 
least two primary mechanisms can be used to remodel chro-
matin structure. One mechanism involves changing the loca-
tion and conformation of the nucleosomes through the use of 
ATP-dependent protein complexes such as SWI/SNF [58-
62]. The second mechanism involves covalent modifications 
of histone N-terminal histone tails that protrude from the 
chromatin structure [57, 63]. Studies examining the role of 
Rb:E2F mediated cell cycle arrest have identified key Rb 
interactions with chromatin remodeling factors [64]. Rb-
mediated chromatin remodeling effectively represses E2F 
transcriptional activity [64]. The particular associations be-
tween Rb and chromatin remodeling factors have been found 
to be dependent on the type of cell cycle exit [56].  
  General mechanisms of Rb-mediated chromatin remodel-
ing include the recruitment of ATP-dependent chromatin 
remodeling complexes. One particular complex member 
associated with Rb during cell cycle arrest is the SWI/SNF 
complex and its central subunit, Brahma (BRM) [65, 66]. 
These chromatin remodeling complexes use the energy de-
rived from ATP hydrolysis to alter the chromatin structure. 
The presence of the conserved Rb-binding motif, LXCXE, in 
BRM suggests that this may be the initial chromatin remod-
eling factor which binds to the Rb pocket domain, and pre-
pares the nucleosomes for heterochromatin formation [65].  
  Following BRG binding and nucleosome sliding, stable 
repression of Rb:E2F is achieved through covalent modifica-
tions of protruding histone N-terminal tails [66]. Deacetyla-
tion of histones is mediated through the recruitment of his-
tone deacetylases (HDACs) via  the Rb associated protein 
RbAp48. The primary site of deacetylation during cell cycle 
exit is K9AcH3, which later becomes methylated and a site 
of HP1 binding [67]. Following K9AcH3 deacetylation, the 
next set of covalent histone modifications includes the meth-
ylation of lysine residues by histone methyltransferase 
(HMTase). The HMTase, Suv39H1, binds to Rb through the 
LXCXE binding motif and methylates lysine 9 of histone H3 
[62, 67, 66]. Transcriptional repression of E2F through het-
erochromatin formation is also promoted through the actions 
of HP1 binding methylated K9H3 histones [66]. Binding of 
HP1 mediates higher levels nucleosome structure facilitated 
by HP1 dimerization, leading to multiple histone recruitment 
and tight chromatin packing [68]. Although these chromatin 
modifications are well cited in the literature, there are slight 
modifications to these complexes in cells undergoing a short-
term pause in the cell cycle (G1 arrest) and those entering a 
















Fig. (5). Chromatin remodeling complexes associated with the Rb 
family. Complex composition changes with the duration and type of 
cell cycle arrest. Pictured are the complex members in A) cells 
undergoing general G1 arrest and B) cells undergoing a reversible 
exit from the cell cycle (quiescence) [108]. 
  Quiescent transitions are controlled in a reversible man-
ner, mediated in part by the competing actions of histone 
acetyltransferases (HATs) and HDACs on the histones asso-
ciated with the Rb:E2F complex. Although the general 
model of chromatin remodeling complexes have been char-
acterized for cell cycle arrest, specific complexes character-
izing prolonged and reversible cell cycle exit are only begin-
ning to be explored. Chromatin modifying factors that have 
been found to interact with pRb2/p130 during quiescence 
include components of the drosophila Rb-E2F and Myb 
(dREAM) complex initially discovered in arrested droso-
phila embryos, and the methyl-histone lock, L3MBTL1 [63, 
69]. These complexes contain additional quiescent specific 
factors which are thought to regulate quiescence by compact-
ing nucleosome structures in a manner that is dependent on 
mono- and di-methylation of histone H3K9 [62]. Recruit-
ment of L3MBTL1 allows the binding of at least two nu-
cleosomes simultaneously through the recognition of N-
terminal histone modifications [62]. This raises the possibil-
ity that dREAM may promote specific and reversible hetero-
chromatin structure through the recruitment of L3MBTL1, 
locking methylated histones ([63]; Fig. (5)).  
  In accordance with quiescence-dependent Rb expression, 
pRb2/p130:E2F-4 but not pRb/p105:E2F-1 interacts with 
members of the dREAM complex [70]. During quiescence, 
the dREAM complex binds to more than 800 promoters and 
is found in association with E2F target gene promoters [70]. 
Components of the dREAM complex include LIN9, F25965 
(LIN37), LOC91750 (LIN52) and Tesmin [62]. Although the 
functions of F25965 and LOC91750 have not yet been char-
acterized, knock-out experiments indicate that LIN9 acts as a 
tumor suppressor by inhibiting DNA synthesis independent 
of Rb within the G1 phase [71]. Tesmin also plays a role in 
the DNA binding as required by the dREAM complex [72].  
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Cell Cycle Regulation by MicroRNAs  
  MicroRNAs are small non-coding ~23nt RNAs that have 
recently emerged as key post-transcriptional modifiers of 
gene expression during periods of environmental stress [73-
75]. After being transcribed and processed, mature microR-
NAs are incorporated into the RNA-induced silencing com-
plex (miRISC) to target mRNAs based on sequence com-
plementation in the 3 untranslated regions (UTRs). These 
microRNAs are predicted to control the activity of 30-50% 
of all protein coding genes and have been shown to exert 
their effects on differentiation, apoptosis, longevity, prolif-















Fig. (6). MicroRNA biogenesis. Primary transcripts are transcribed 
by RNA polymerase II and excised by a series of riboendonucleases 
into single-stranded mature microRNA stuctures. Mature mi-
croRNA structures are then loaded into the microRNA induced 
silencing complex (miRISC) and represses translation of targeted 
mRNA through 3- UTR binding.  
  MicroRNAs are derived from RNA transcripts that fold 
into imperfect hairpin structures, classified as primary-
microRNAs [76]. Still located within the nucleus, the pri-
mary-microRNA transcript is processed by the RNase III 
type endonuclease, Drosha [77-80]. The Drosha complex 
processes primary-microRNAs into ~70nt hairpin structures 
known as pre-microRNA. Drosha processing is necessary to 
remove introns (mirtrons) that would otherwise interfere 
with microRNA function [81-83]. Pre-microRNAs are then 
exported from the nucleus into the cytoplasm, via exportin 5, 
and are then further processed into mature microRNA struc-
tures [77-80]. The processing of pre-microRNAs into mature 
microRNAs is mediated by the endonuclease, Dicer [re-
viewed in 73, 79, 80, 84]. 
  After processing and formation, mature microRNAs are 
assembled into microRNA-induced silencing complexes 
(miRISC). The process of assembly is currently not well 
understood, but likely involves a dynamic process coupled 
with the pre-microRNA processing by Dicer [77-80]. Several 
studies has proposed that the miRISC mediates translational 
repression via binding of the 5’ cap structure of the target 
mRNA, thereby remodeling and inhibiting translational ini-
tiation complexes, while also targeting the mRNA transcript 
to p-bodies [85]. Similar to the proposed role of microRNAs 
in the hibernating ground squirrel (Spermophilus tridecem-
lineatus) and frozen wood frog (Rana sylvatica), this model 
provides a process where p-bodies may facilitate long-term 
mRNA storage; allowing rapid re-initiation of translation of 
mRNA transcripts immediately after anoxic stress recovery 
[75, 86]. It is known that the number of p-bodies increase 
with the onset of environmental stresses, including nutrient 
deprivation and osmotic stress [87]. This provides an intrigu-
ing basis for microRNAs to establish rapid biological con-
trols regulating cell cycle exit during entry into anoxia pro-
viding a mechanism by which anoxic turtles can rapidly 
emerge from a suspended condition and reinstate normal cell 
cycle activity. 
  Similarly, results of a study by Dresios suggested that 
microRNAs (miR-125b) act in response to cold stress [88]. 
MiR-125b is known to be involved in cell cycle arrest and 
has been shown to act as a tumor suppressor gene and to 
regulate cell proliferation in human cancers since one of its 
targets includes E2F-2 [89]. Although this study does not 
present the severe temperature extremes or environmental 
stresses that many other organisms facilitate, it does provide 
novel and intriguing suggestions that microRNAs may pro-
vide an important mechanism in translational repression in 
response to environmental stresses such as anoxia.  
  Fine scale regulation of the cell cycle helps maintain a 
timely and coordinated progression as well as genetic stabil-
ity [90]. Specifically, microRNAs targeted by p53 have been 
shown to increase expression levels during cell cycle arrest. 
The p53-targeted microRNAs include miR-34a, miR-20a, 
miR-17-5p, miR-let-7a and miR-615 [91, 92]. Having both 
experimental and bioinformatic analysis to support their role 
in the cell cycle, these microRNAs present interesting sub-
jects for further examination (Table 1). Recent studies show 
that when cells were transinfected to express high levels of 
miR-16, an increased number of cells were found to be in 
quiescence, with corresponding decreases in the numbers of 
cells in S, G2 and M phases [93] Results from these experi-
ments suggest that increased miR-16 expression alone have 
the ability to arrest cells and promote entry into quiescence. 
4. OXYGEN DEPRIVATION AND THE MECHA-
NISMS OF CELL CYCLE ARREST 
  What are the mechanisms for hypoxia induced cell cycle 
arrest? Researchers have generalized numerous hypoxia sen-
sitive pathways and checkpoints in several organisms, high-
lighting the multiple interconnected pathways at play and 
further emphasizing the importance of an appropriate model 
system. Current studies examining the state of the cell cycle 
under hypoxic stress have largely been limited to the early 
developmental stages of brine shrimp (Artemia franciscana) 
embryos, zebra fish (Danio rerio) embryos, nematodes 
(Caenorhabditis elegans) and fruit flies (Drosophila mela-
nogaster) [3-7]. Research focusing on the developing nema-
tode has found that larval stages can enter a reversible sus-
pended animation in all stages of the cell cycle when pre-
sented with an anoxic stress [3, 7]. Similar to research car-
ried out with nematodes, studies utilizing GFP-kinesin in the 580    Current Genomics, 2009, Vol. 10, No. 8  Biggar and Storey 
early embryonic stages of fruit fly development have shown 
that hypoxia (less than 2% oxygen) induces a prolongation 
of all cell cycle stages. Furthermore, when exposed to anoxia 
these embryos enter a reversible arrest at one of two phases: 
mitosis (aligned, nonsegragated chromatids) and a G1-like 
phase (early embryos do not possess a true G1 phase) [7]. 
Although complete analysis of the cell cycle has not yet been 
studied, it is known that during the embryonic stages, brine 
shrimp can enter a quiescent state for several years; a state 
facilitating the long-term arrest of the cell cycle and allowing 
for development to resume when environmental conditions 
become favorable for growth [4, 5, 7]. In the early embry-
onic stages, zebra fish have been found to enter a state of 
reversible arrest when presented with an anoxic environment 
[6]. Flow cytometric studies have indicated that these em-
bryos enter an arrest in the S and G2 (4n) phases of the cell 
cycle. It has been postulated that these phases of the cell cy-
cle may have a higher oxygen demand than other phases [6]. 
Although there have been several studies characterizing the 
anoxic response in developing organisms, cell cycle arrest 
has not yet been characterized for developmentally mature 
vertebrate organisms tolerant of severe anoxia.  
  The study of hypoxia induced cell cycle arrest is compli-
cated by many factors including the requirement of many 
key players (Cyclins, Cdks and CKIs) and the high degree of 
redundancy between multiple pathways (such as the Rb and 
E2F family members). Severe hypoxia is a unique stress as 
cells undergo a rapid replication arrest without accumulating 
DNA damage [41, 42]. Hypoxia has also received research 
attention as it is physiologically relevant, occurring during 
normal embryogenesis, ischemic injuries and tumor progres-
sion [42]. Given the clinical implications pertaining to hy-
poxia, the proper selection of a model system becomes criti-
cal. Relying on model organisms can induce a sense of over-
simplification and an overestimate of commonalities directed 
towards other unexplored species. Ideally, research begins 
with simple and well-understood organisms and then builds 
upon this knowledge with wider and more-complex organ-
isms. Problems arise when responses seen in the simple 
model are taken to represent a complete understanding of a 
central process, including hypoxic cell cycle arrest. Research 
carried out with model organisms has proven to be a useful 
way to analyze cellular processes [94]. However, these or-
ganisms have also been subject to several biases. For exam-
ple, model organisms may be highly available and easy to 
use; however, there are also restrictions to studying a small 
number of species and attempting to generalize across a wide 
range of biological diversity. In order to address these issues 
in hypoxic cell cycle regulation there needs to be more focus 
on research carried out in non-model organisms that better 
facilitate the anoxic stress response pathway. 
  Anoxia in a vertebrate animal model system, capable of 
undergoing physiological and molecular reorganization in 
response to low oxygen, provides an invaluable tool to dis-
sect the anoxic response and proliferation control pathways. 
One such vertebrate animal capable of surviving extreme 
reductions in oxygen consumption, and worthy of in-depth 
exploration at the molecular level, is the red eared slider 
(Trachemys scripta elegans). This turtle has been extensively 
studied for its ability to suspend breathing and enter an an-
oxic state, facilitating survival for months at a time. This 
ability is clearly fascinating and has been the focus of nu-
merous physiological, molecular, and biochemical studies 
[reviewed in 95, 96].  
The Anoxic Turtle 
  Turtles comprise a small taxon that has attracted the at-
tention of biologists for centuries. However, despite this at-
tention, a major portion of their life cycle has been left rela-
tively untouched [97]. In their northern ranges, turtles spend 
upwards of half of their lives in an over-wintering state, the 
majority of which is located in ice-covered ponds where 
oxygen levels can drop drastically [97, 98]. Oxygen depriva-
tion is a particularly challenging stress due to its conse-
quences for ATP production, a stress that can rapidly kill 
intolerant species [99, 100]. The turtle achieves anoxia toler-
ance primarily through several mechanisms: 1) metabolic 
rate suppression 2) high capacity for glycolytic energy pro-
duction including large reserves of substrates (glycogen) and 
3) effective methods for dealing with end products (acid 
buffering, lactate storage in shell). Each of these mechanisms 
converge on the conservation of ATP stores [95, 101].  
Metabolic Rate Depression 
  Common themes in scientific literature include the asso-
ciations between metabolic rate, energy status and stress 
resistance [95, 101]. In many animals, low energy status elic-
Table 1.  Key Regulatory Cell Cycle Components Experimentally Determined to be Targeted by microRNAs 
MicroRNA mRNA  Target References 
miR-34a  E2F-3, Cyclin D and Cdk 6  [109, 112] 
miR-16/miR-15  Cdk 4, Cyclin D & E, cdc25a  [93, 112] 
miR-107  Cdk 6, cdc25a, Cyclin E, E2F-1  [110] 
miR-20a  Cdk 2, E2F-1 and Cyclin A  [111, 112] 
miR-17-5p  E2F-1 and Cyclin A  [111] 
miR-let-7a  cdc25a and Cdk 6  [112] 
miR-148a E2F-3  [113] 
miR-103  Cyclin E, cdc25a, Cdk 6, E2F-1  [114] Perspectives in Cell Cycle Regulation  Current Genomics, 2009, Vol. 10, No. 8    581 
its an altered pattern of gene expression that results in re-
duced rates of metabolism and is coincident with entry into a 
quiescent state [95, 102]. Hibernating and/or torpid mam-
mals often suppress their metabolism to less than 10% of that 
of active animals, whereas anoxic turtles have been known to 
suppress their metabolic demands to that of 15% of nor-
moxic values [102].  
  Although it is clear that anoxic survival relies on the sup-
pression of ATP consuming processes, the state of the cell 
cycle in anoxia tolerant organisms remains largely unknown. 
Proliferation of cells is clearly an energy-expensive biosyn-
thetic process, so it would make sense that these activities 
are suppressed to a minimum under anoxic conditions. Tak-
ing into account that ATP supplies become limited under 
anoxia stress, in concurrent with reports by Mazia who sug-
gests that withdrawal of energy yielding substances will in-
duce G1 arrest if applied before S-phase, a substantial G1/G0 
arrest during anoxia seems highly probable [103]. The de-
manding energetics of mitosis provides an intriguing sugges-
tion that the cell cycle may arrest in proliferating tissues in 
order to facilitate metabolic rate depression and play an im-
portant role in cellular responses to environmental stresses.  
  Indeed, studies with other systems of facultative meta-
bolic arrest, such as mammalian hibernation, do induce cell 
cycle arrest in hypometabolic states. For example, studies 
with hibernating ground squirrels (Crypturellus undulatus) 
indicate that highly regenerative tissues such as intestinal 
epithelial are suspended in the 2N DNA range (G1/G0) (90%) 
during hibernation as compared to active states (79%); 
whereas, both S and G2/M phases are decreased during hi-
bernation [104, 105]. These results suggest that DNA syn-
thesis is markedly reduced during the hibernation period. As 
previously mentioned, in other species with varying degrees 
of stress tolerance, sites of cycle arrest appear to differ. 
However, a number of DNA replication checkpoint proteins 
have been shown to be involved in general hypoxic cycle 
arrest, and some have been suggested to transduce the stress 
signal [7]. These include Cdk 1, Cdk 2, Cdk 4, Cdk 6, Cy-
clins A, D, and E, Rb pocket proteins and specific CKIs 
(specifically p21, p27, and p16) [12, 19, 21, 29, 36, 41, 58]. 
  Current research in our lab is focused towards the bio-
chemical adaptations that support survival of anoxia by the 
turtle, T.s.elegans. In summary, the mechanisms of cell cycle 
arrest could contribute substantially to an overall reduction 
in energy consumption in the anoxic state. Arrest of cellular 
proliferation should be crucial for ATP homeostasis in the 
anoxic state, since aberrant continuation of the cell cycle 
would lead to rapid depletion of energy stores.  
  Activation of an Rb:E2F mediated quiescent phase dur-
ing periods of severe stress is a common response in hypoxia 
tolerant organisms, such as C.elegans and D.melanogaster 
[7, 14]. Therefore, it is important to learn how developmen-
tally mature vertebrate systems tolerant avoid energy deple-
tion and whether this is accomplished through the evolution-
arily conserved mechanism of Rb:E2F mediated G1 cell cy-
cle arrest. The effect of anoxia on Rb phosphorylation and 
the hypophosphorylated state found in many hypoxia toler-
ant organisms may perhaps be a mechanism by which cells 
exit the cell cycle in G1 or G0 quiescence arrest, mediated in 
part by many of the typical stress response pathways dis-
cussed in this review. The effect of anoxia on other impor-
tant proteins involved in G1/S transition, which include E2F 
and Cyclins D and E are not yet defined. Furthermore, 
kinases such as ATM, and its downstream effector Chk2, 
may be crucial for the sensing and implementation of an-
oxia-responsive transition into cell cycle arrest.  
  Furthermore, long term oxygen deprivation may facilitate 
a new and novel mechanism of cell cycle arrest, distinct 
from nematodes, brine shrimp, fruit flies and zebra fish. Ex-
amination of the key mechanisms discussed in the review 
will provide a critical overview and elucidation of the main 
mechanisms facilitating cell cycle arrest and direct future 
studies in ischemic injury and tumor growth.  
 Clearly,  T.s.elegans provides an excellent model system 
for studying the process of anoxic cell cycle arrest, and the 
current research provides many new and exciting questions 
regarding both generalized processes and mechanisms of 
arrest. Many studies focused on cell cycle arrest examine the 
mechanisms of arrest in invertebrate or vertebrate embryo 
model organisms. These studies provide a solid foundation 
for further studies, but do not highlight the complexities of 
developed vertebrate life as would studies on the anoxic tur-
tle. Research on the anoxic turtle will most certainly demon-
strate the cellular and molecular mechanisms underlying the 
response to anoxia and the control of cellular proliferation. 
These studies will also provide a wide comparative data 
from biologically diverse organisms and highlight the essen-
tial processes eliciting cell cycle control in an anoxic envi-
ronment. Discovering the commonalities of response path-
ways in organisms as diverse as nematodes, fruit flies, and 
turtles will undoubtedly lead to refined treatment of ischemic 
injuries and to hypoxic tumor cores which are often resistant 
to radiation and chemotherapy [106].  
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